ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

被引：0
|
作者：
Lifeng Wang
Jia Wei
Xiaoping Qian
Haitao Yin
Yang Zhao
Lixia Yu
Tingting Wang
Baorui Liu
机构：
[1] Drum Tower Hospital Affiliated to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University,Department of Oncology
[2] Nanjing Medical University,Department of Epidemiology and Biostatistics, Epidemiology and Biostatistics Graduate Program, Data Analysis Center, School of Public Health
来源：
BMC Cancer | / 8卷
关键词：
Docetaxel; Gastric Cancer Patient; Nucleotide Excision Repair; Malignant Pleural Effusion; BRCA1 Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens
    Rice, JC
    Ozcelik, H
    Maxeiner, P
    Andrulis, I
    Futscher, BW
    CARCINOGENESIS, 2000, 21 (09) : 1761 - 1765
  • [32] ERCC1 isoform expression levels characterized using a monoclonal antibody to ERCC1 and drug sensitivity
    Hayashi, Kohei
    Tong, Ying
    Oishi, Takayuki
    Chen, Lichao
    Sasaki, Yuka
    Onodera, Takae
    Yanagihara, Kazuyoshi
    Nakao, Kazuhiko
    Yamada, Yasuhide
    Masutani, Mitsuko
    CANCER SCIENCE, 2022, 113 : 1206 - 1206
  • [33] Treatment guided by ERCC1, RRM1, and BRCA1 protein expression in patients with advanced-stage NSCLC
    Han, B.
    Shen, J.
    Gao, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas
    Saebo, Mona
    Skjelbred, Camilla Furu
    Nexo, Bjorn Andersen
    Wallin, Hakan
    Hansteen, Inger-Lise
    Vogel, Ulla
    Kure, Elin H.
    BMC CANCER, 2006, 6 (1)
  • [35] Increased mRNA expression levels of ERCC1, OGG1 and RAIin colorectal adenomas and carcinomas
    Mona Sæbø
    Camilla Furu Skjelbred
    Bjørn Andersen Nexø
    Håkan Wallin
    Inger-Lise Hansteen
    Ulla Vogel
    Elin H Kure
    BMC Cancer, 6
  • [36] BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
    Taron, M
    Rosell, R
    Felip, E
    Mendez, P
    Souglakos, J
    Ronco, MS
    Queralt, C
    Majo, J
    Sanchez, JM
    Sanchez, JJ
    Maestre, J
    HUMAN MOLECULAR GENETICS, 2004, 13 (20) : 2443 - 2449
  • [37] BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
    Crino, Lucio
    Queralt, Cristina
    Felip, Enriqueta
    Scagliotti, Giorgio
    Pastorino, Ugo
    Font, Albert
    Miguel Sanchez, Jose
    Moran, Teresa
    Taron, Miquel
    Rosell, Rafael
    ANNALS OF ONCOLOGY, 2004, 15 : 170 - 170
  • [38] The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
    Weberpals, Johanne
    Garbuio, Kyla
    O'Brien, Anna
    Clark-Knowles, Katherine
    Doucette, Steve
    Antoniouk, Olga
    Goss, Glenwood
    Dimitroulakos, Jim
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) : 806 - 815
  • [39] ERCC1 and BRCA1 mRNA expression predicts the clinical outcome of non-small cell lung cancer receiving platinum-based chemotherapy
    Feng Xian-jun
    Qin Xiu-guang
    Zang Li
    Feng Hui
    Wang Wan-ling
    Liu Dong
    Li Ping-fa
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2014, 30 (03) : 488 - 492
  • [40] ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy
    Qin, Xiuguang
    Yao, Wenjian
    Li, Weiwei
    Feng, Xianjun
    Huo, Xiaoqing
    Yang, Shujuan
    Zhao, Hui
    Gu, Xiaomeng
    TUMOR BIOLOGY, 2014, 35 (05) : 4697 - 4704
12345